Delivery Order SPE2DB20D6037-SPE2DB23FD0SK
Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,001.76 and has an ultimate completion date of May 10, 2024. The contract is for the delivery of MOVIPREP powder packets, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a $1,314.06 firm fixed-price delivery order for the supply of MOVIPREP powder packets, a specialized pharmaceutical product, with a completion date of June 26, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.30 firm fixed-price contract is for the delivery of MOVIPREP POWDER PACKETS, with a completion date of June 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,230.97, is for the supply of MOVIPREP powder packets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,781.90 contract is for the delivery of MOVIPREP POWDER PACKETS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,201.57, is for the supply of MOVIPREP POWDER PACKETS, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.96 contract is for the supply of MOVIPREP powder packets, a pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA, which allows the agency to place orders for a comprehensive range of pharmaceutical items to support the...
- This federal contract award is for the procurement of MOVIPREP POWDER PACKETS by the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on March 1, 2023, with a ceiling value of $1,712.00 and an ultimate completion date of March 2, 2023. The contract is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.32 to DMS Pharmaceutical Group Inc. for MOVIPREP powder packets, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was executed on August 11, 2025, with no set-aside designation applied. The place of performance is identified as Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, is...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,311.35 and has an ultimate completion date of April 19, 2024. The contract is part of the DLA's Medical Supply Chain program and is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, DMS...